Half-year report · HY
2931.TEDINET S100YVGZ
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥50.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥909m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥73m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥805m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥559m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥888m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥133m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥69.3bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥72.3bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥69.1bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.7bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.8bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.6bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥28.5bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥31.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.2bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥674m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥585m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥514m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.9bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.53 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.9 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.1 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.52 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.8% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥805m |
| Biofuel Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥160m |
| Health Care Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥3.0bn |
| Others Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Others Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥202m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥790m |
| Biofuel Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥114m |
| Health Care Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.8bn |
| Others Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥7m |
| Others Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥218m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 632
| Item | Context | Value | Unit |
|---|---|---|---|
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2026-01-01 | |
| Current period end date | FilingDateInstant | 2026-06-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2025-01-01 | |
| Comparative period end date | FilingDateInstant | 2025-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)出雲 充 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８－１ | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社綺麗創造ホールディングス | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都江東区富岡２丁目１１－６ | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口) | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８－１２ | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)山内 正義 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)千葉県浦安市 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社丸井グループ | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中野区中野４丁目３－２ | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)JP JPMSE LUX RE NOMURA INT PLC 1 EQ CO（常任代理人 株式会社三菱UFJ銀行） | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)ロート製薬株式会社 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)大阪府大阪市生野区巽西１丁目８－１ | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)UBS AG SINGAPORE（常任代理人 シティバンク、エヌ・エイ東京支店） | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京センチュリー株式会社 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区神田練塀町３ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |